Choosing the right targets for the right disease and the right drugs for the right patients is a persisting challenge in drug discovery and clinical care.

We partner with pharmaceutical companies to prioritise the most promising drug targets and candidates for preclinical and clinical development with the goal to maximise clinical study success rates and patient benefit.

Allcyte aims to provide physicians actionable insight on how to match patients with drugs ideally suited for their specific cancer in situations where classical genetics-driven precision medicine does not give precise answers.

Operating at the forefront of functional precision medicine, we do this by measuring drug activity in viable, primary human patient tissues with our Pharmacoscopy® platform at the single cell level to gain a preview of their most likely clinical efficacy. Powered by AI, scaled in the cloud and for the benefit of the patient.

Picture